WORKING WITH US
Harnessing nearly two decades of experience, The Chase Group, Inc. offers standard-setting professional recruitment services in the Life Sciences industry. Because we work exclusively in the substantive areas of global pharmaceuticals, biotechnology, academic medicine and research, non-profits, animal health, diagnostics, medical devices and healthcare communications, our executive recruiters are focused strictly on identifying, targeting and securing the highest quality candidates skilled for these unique markets. By maintaining an extensive network of strategic contacts specific to the Life Sciences industry, The Chase Group can deliver responsive, timely and cost-effective recruitment solutions that meet our clients’ and candidates’ specialized needs.
FINDING A CANDIDATE
Dedication, keen industry insight, individualized service and a competitive spirit unite in The Chase Group’s proprietary approach to recruitment, enabling us to effectively and efficiently secure the high-caliber candidates our clients require.
SECURING A NEW POSITION
Much more than just an executive search firm directory, The Chase Group offers individualized services for both clients and candidates, ensuring that skills, qualifications and personalities are a precise match. For us and for our candidates, each placement signifies more than a job—it may reflect the beginning of an enduring career or the next critical step in one’s professional evolution.
"Find a job you love and never work another day in your life..."
Jan 5, 2012
TCG Successfully Fills Eisai’s Search for Senior Director, Biostatistics/Oncology Dept. Head
TCG starts 2012 with a placement at Eisai for a Senior Director, Biostatistics/Oncology. The key to this search was finding a candidate who was as outstanding in his technical skills as he was with his communications/leadership skills. Eisai is very pleased with our candidate who accepted their... Search details
Dec 16, 2011
TCG secures search contract with Acorda Therapeutics
Nov 28, 2011
Success continues with Eli Lilly’s Diabetes Business Unit
with the successful recruitment of 2 endocrinologists!
Nov 14, 2011
TCG Recruits Pre-eminent Epileptologist to Lundbeck
Lundbeck’s senior management team is now stronger with the addition of Jouko Isojärvi, MD/PhD as Senior Director, Medical Affairs. Dr. Isojärvi had a prominent academic career at the University of Oulu, Finland, before moving to the U.S. Since joining the pharmaceutical industry, he has... Read more
Nov 1, 2011
TCG’s partnership with Eli Lilly’s Oncology franchise continues
with the successful placement of pathologist Dr. Charles Caldwell into their Diagnostic Experimental Medicine group. Dr. Caldwell joins Lilly in the position of Sr. Medical Fellow!
Oct 27, 2011
TCG and ISIS Pharmaceuticals celebrate success in Bioinformatics
The Chase Group was pleased to help Isis Pharmaceuticals recruit an Associate Director, Bioinformatics (deep sequencing) to join its antisense drug development team. This challenging scientific search ended successfully with the hiring of Chris Hart, PhD, who will be at the center of Isis research... Click for search details
Oct 27, 2011
Rafael Muniz, MD joins Lundbeck’s Senior Leadership Team
The Chase Group is proud to announce our placement of Rafael Muniz, MD as Vice President, Medical Affairs for Lundbeck, Inc. Dr. Muniz was selected after a very competitive search process. He joins Lundbeck as the company positions itself for new product development and introduction in the US,... Click for further details
Oct 10, 2011
Lilly Tailored Therapies unit selects TCG
to recruit for their Laboratory Experimental Medicine group!
Oct 3, 2011
Business Development Veteran Joins The Chase Group
FOR IMMEDIATE RELEASE
Contact: Karen Leathers (913) 663-3100 ext 6328
Overland Park, KS – October 3rd , 2011 – The Chase Group, a trusted partner for nearly 20 years in life sciences executive recruiting, is continuing to grow with the addition of Rick Hertzenberg as Vice President of... Read More
Sep 26, 2011
TCG kicks off Head of Biostatistics search for Eisai Pharmaceuticals
